Related Experiment Video
Updated: Jun 21, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Anti-inflammatory treatment of asthma: differentiation and trial-and-error
1Asthma and Allergy Clinic, Children's Clinic Randers, 8900 Randers, Denmark. bkr@boerneklinikkenranders.dk
Insights
Asthma treatment in children requires personalized strategies based on age and type. Inhaled corticosteroids are effective for most school-aged children, while a trial-and-error approach may suit younger children or those with mild asthma.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
- Clinical Therapeutics
Background:
- Limited evidence exists for anti-inflammatory asthma treatments in specific pediatric phenotypes.
- Recent guidelines emphasize the need for tailored treatment strategies in children.
Purpose of the Study:
- To outline evidence-based treatment strategies for pediatric asthma phenotypes.
- To guide clinical decision-making for initiating anti-inflammatory therapy in children.
Main Methods:
- Review of current guidelines and consensus reports on pediatric asthma management.
- Analysis of factors influencing treatment decisions, including age, asthma type, severity, and patient characteristics.
Main Results:
- Inhaled corticosteroids are effective across the spectrum of asthma in school-aged children.
- For toddlers with viral wheeze and children with mild asthma, a trial-and-error approach with oral leukotriene receptor antagonists or inhaled corticosteroids may be considered.
Conclusions:
- Individualized treatment is crucial for effective pediatric asthma management.
- A trial-and-error approach is warranted for specific asthma types and age groups.
Unlabelled:
The relative lack of evidence for anti-inflammatory treatment of some phenotypes of asthma in children has been highlighted in recent guidelines and consensus reports specifically aiming at the paediatric population. Consequently, we are left with a need for defining treatment strategies in the clinical setting. The decision to initiate antiinflammatory treatment should be based on assessments of the individual child's age, the type of asthma, severity, heredity and atopic condition, adherence factors and sensitivity to systemic adverse effects of treatment options. Inhaled corticosteroids are potent anti-inflammatory agents that are effective in the whole spectrum of asthma in school age children. In toddlers with viral wheeze and in children with mild asthma oral leukotriene receptor antagonists or inhaled corticosteroids may be given on a trial-and-error basis.
Conclusion:
To treat all children with asthma equally effectively from infancy through adolescence does not mean that they should be treated identically and in some types of asthma a trial-and-error approach may be warranted.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Asthma I: Introduction
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: